In the last trading session, 1.42 million shares of the Outset Medical Inc (NASDAQ:OM) were traded, and its beta was 2.11. Most recently the company’s share price was $1.29, and it changed around -$0.03 or -2.27% from the last close, which brings the market valuation of the company to $67.78M. OM currently trades at a discount to its 52-week high of $6.37, offering almost -393.8% off that amount. The share price’s 52-week low was $0.44, which indicates that the current value has risen by an impressive 65.89% since then. We note from Outset Medical Inc’s average daily trading volume that its 10-day average is 0.99 million shares, with the 3-month average coming to 950.23K.
Outset Medical Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.80. If we narrow it down even further, the data shows that 0 out of 6 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended OM as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Outset Medical Inc is expected to report earnings per share of -0.41 for the current quarter.
Outset Medical Inc (NASDAQ:OM) trade information
Instantly OM has showed a red trend with a performance of -2.27% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.4500 on recent trading dayincreased the stock’s daily price by 11.03%. The company’s shares are currently down -76.16% year-to-date, but still up 9.32% over the last five days. On the other hand, Outset Medical Inc (NASDAQ:OM) is 68.19% up in the 30-day period. We can see from the shorts that 2.9 million shares have been sold at a short interest cover period of 3.2 day(s).
The consensus price target as assigned by Wall Street analysts is $3, which translates to bulls needing to increase their stock price by 57.0% from its current value. Analyst projections state that OM is forecast to be at a low of $3 and a high of $3.
Outset Medical Inc (OM) estimates and forecasts
Outset Medical Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -69.79 percent over the past six months and at a 30.74% annual growth rate that is well above the industry average of 24.50%. The year-over-year growth rate is expected to be -13.75%, down from the previous year.
Consensus estimates provided by 6 financial analysts predict the company will bring in an average of 27.91M in revenue for the current quarter. 5 analysts expect Outset Medical Inc to make 29.66M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 30.5M and 28.17M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -8.49%. Forecasts for the next quarter put sales growth at 5.31%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -15.08%. Outset Medical Inc earnings are expected to increase by 26.22% in 2024, but the outlook is positive 23.80% per year for the next five years.
OM Dividends
Outset Medical Inc’s next quarterly earnings report is expected to be released in January.
Outset Medical Inc (NASDAQ:OM)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.11% of Outset Medical Inc shares, and 52.20% of them are in the hands of institutional investors. The stock currently has a share float of 53.32%. Outset Medical Inc stock is held by 110.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 15.1214% of the shares, which is about 7.7 million shares worth $29.63 million.
AMERIPRISE FINANCIAL INC, with 10.2162% or 5.2 million shares worth $20.02 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
